Latest News

As the Canadian market navigates policy shifts and global uncertainties, the TSX is on track for its strongest calendar-year return since 2009, offering investors much to be thankful for. In this context of robust equity gains, identifying promising investment opportunities remains crucial. Penny stocks, though an older term, still represent a viable area for finding smaller or less-established companies with potential. By focusing on those with strong financials and growth potential,...

Electrovaya Inc. ( TSE:ELVA ) shareholders might be concerned after seeing the share price drop 14% in the last...

Corporación Moctezuma, S.A.B. de C.V. ( BMV:CMOCTEZ ) is about to trade ex-dividend in the next 2 days. The ex-dividend...

Wondering if Eastman Chemical is a beaten down value play or a value trap at current levels? You are not alone. This article aims to unpack exactly that. With the share price around $60.66 and down 31.5% year to date and 37.8% over the past year, the market has clearly reset its expectations and is forcing investors to rethink the risk reward profile. Recent headlines have focused on Eastman’s strategic push into specialty materials and circular recycling initiatives, alongside ongoing...

Wondering if Abbott Laboratories is still worth buying after its long run as a healthcare blue chip, or if most of the upside is already priced in? Despite a modest slip of 2.4% over the last week and being roughly flat over 30 days, the stock is still up 10.5% year to date and over the past year, hinting that long term sentiment remains constructive at around $125.40 per share. Recent headlines have focused on Abbott’s continued push in medical devices and diagnostics, alongside regulatory...

Recent move and performance context 10x Genomics (TXG) has been quietly grinding higher, with the stock up about 36% over the past month and 30% in the past 3 months, after a choppy multi year stretch. See our latest analysis for 10x Genomics. That recent surge sits against a mixed backdrop, with a solid year to date share price return but a still deeply negative three year total shareholder return that shows how long term holders have been tested. This suggests that momentum is rebuilding as...

Methode Electronics (MEI) just posted Q2 2026 results with revenue of $246.9 million and a basic EPS loss of $0.28, as the trailing twelve months show revenue of $984.4 million alongside a basic EPS loss of $1.78. The company has seen quarterly revenue move in a relatively tight band from $292.6 million in Q2 2025 to $246.9 million in Q2 2026, while EPS has stayed in negative territory across the same stretch. This is setting the stage for investors to focus on how long current margin...

Build-A-Bear Workshop (BBW) has reported another busy stretch, with Q2 2026 revenue of about $124 million and basic EPS of $0.94, following Q1 2026 revenue of roughly $128 million and basic EPS of $1.17 as the company continues to cycle strong results from late 2025, when Q4 revenue was around $150 million and EPS reached $1.63. Over the last year, trailing twelve month revenue has climbed from approximately $480 million to $523 million and EPS has moved from $3.49 to $4.48. This sets up the...

On 14 November 2025, Mizuho Financial Group’s board met to consider a repurchase of common stock, signaling a renewed focus on capital management and shareholder returns. This move puts fresh attention on how Mizuho balances cash deployment between buybacks, investments, and rising cost pressures across its global banking and securities operations. We’ll now explore how the planned share repurchase discussion could reshape Mizuho’s investment narrative around capital allocation and earnings...

Wondering if Packaging Corporation of America is quietly turning into real value at the right price? This breakdown will help you decide whether PKG deserves a spot on your buy list or just your watchlist. The stock has pulled back recently, with shares at $196.63 after a 3.4% drop over the last week and a 12.7% slide year to date, even though the 3 year and 5 year returns are still up 58.0% and 68.6% respectively. Behind those moves, investors have been reacting to shifting expectations...

Wondering if Dr. Ing. h.c. F. Porsche is finally trading at a price that makes sense, or if the market is still misreading the story? Let us unpack what the current share price might really be saying about value. Over the last week the stock has climbed about 5.0%, adding to a 4.9% gain over the past month. Yet it is still down roughly 19.5% year to date and 16.4% over the last year, which suggests sentiment is still catching up with recent moves. Those swings sit against a backdrop of...

Wondering if New York Times at around $64 is still a smart buy or if most of the upside is already priced in? This article unpacks what the market might be missing. The stock has slipped about 1.6% over the last week, but is still up 10.9% in the past month, 22.4% year to date and 18.3% over the last year, with a 93.2% gain over three years signaling the market has steadily rerated the story. Recent headlines have focused on the Times expanding its digital subscription bundles, from news and...

If you are wondering whether ACV Auctions is a beaten down bargain or a value trap, you are in the right place. We are going to unpack what the current share price is really telling us. The stock has slipped about 11.8% over the last month and is down roughly 62.3% year to date and 64.0% over the past year, a trajectory that has sharply reset market expectations around growth and risk. Investors have been reacting to a mix of factors, including shifting sentiment around online auto...

In recent weeks, IMAX has held an investor day outlining three-year financial goals, pursued deeper partnerships such as its merchandise and IP memorandum with Wanda Film, and highlighted upcoming tentpole releases and re-release initiatives aimed at drawing broader audiences to its premium large-format screens. Together, these moves suggest IMAX is trying to shift from a pure box office technology play toward a wider entertainment platform that monetizes its brand, footprint, and fan...

Marex Group (MRX) is back in the spotlight after a wave of securities class action filings accused the firm of a multi year accounting scheme involving off balance sheet entities and fictitious trades. See our latest analysis for Marex Group. Despite the legal overhang, Marex’s share price has climbed to about $37.54, with a roughly mid teens year to date share price return and a stronger one year total shareholder return, suggesting momentum is still building rather than fading. If these...

Wondering if Linde at around $403 a share is still worth buying, holding, or finally trimming? This breakdown is for you if you care about paying a fair price for quality growth. The stock is down about 1% over the last week, 3.4% over the past month, and 2.5% year to date, but longer term it is still up 25.5% over 3 years and 72.4% over 5 years, a mix that can signal either a healthy pause or shifting risk perceptions. Recent headlines have focused on Linde expanding in high demand...

Constellation Energy (CEG) has been on investors’ radar after securing a $1 billion federal loan to restart its Three Mile Island reactor, backed by a 20 year power purchase agreement with Microsoft. See our latest analysis for Constellation Energy. Those moves, combined with the Three Mile Island restart and a string of long term AI data center contracts, have helped fuel strong momentum, with the share price up sharply year to date while three year total shareholder returns remain...

The Cosmo Pharmaceuticals N.V. ( VTX:COPN ) share price has done very well over the last month, posting an excellent...

If you are wondering whether Dow's beaten down share price could actually be setting up a value opportunity, you are not alone in asking whether the current level reflects pessimism or hidden upside. Over the last week the stock has slipped around 4.3%, but it is still up about 1.2% over the past month, and that sits against a tough backdrop of roughly 42.2% losses year to date and about 41.7% over the last year. Recent headlines have focused on Dow's ongoing cost discipline and portfolio...

Logan Group (SEHK:3380) is back in the spotlight after moving past the halfway mark on its RMB13.66 billion onshore debt restructuring. More than 62% of public bond principal is now covered by new arrangements. See our latest analysis for Logan Group. The restructuring progress seems to be changing how investors price in Logan Group’s risk, with a strong 90 day share price return of 71.74% and a 1 year total shareholder return of 41.07% hinting that momentum is rebuilding after years of heavy...

If you are wondering whether ServiceNow is a bargain or just an expensive growth story at today’s price, you are not alone. This breakdown is designed to cut through the noise and focus on what the numbers really say about value. After a choppy stretch, the stock is up about 4.5% over the last week but still down around 5.5% over the past month and roughly 20.4% year to date. A 25.3% slide over the past year contrasts sharply with its strong 111.7% three year gain. Recent headlines have...

Some Keysight Technologies, Inc. ( NYSE:KEYS ) shareholders may be a little concerned to see that the Non-Executive...

If you are wondering whether DocuSign is quietly setting up for a comeback or if the easy money has already been made, this breakdown is for you. The stock has clawed back some ground recently, up 3.2% over the last week and roughly flat over the past month. It is still down 21.3% year to date and 15.0% over the last year, even after a 62.5% gain over three years. Behind those choppy returns, investors are still digesting DocuSign's evolution from a high growth pandemic winner to a more...

Wondering if Calix at around $53.65 is still a smart buy after its big run, or if the easy money has already been made? This breakdown is designed to give you a clear, valuation focused view. Despite short term volatility with the stock down 3.9% over the last week and 18.0% over the last month, Calix is still up 58.3% year to date and 63.7% over the last year, while delivering a 115.5% gain over five years. Recent moves have been shaped by ongoing enthusiasm around Calix's role in broadband...